Skip to main content

Toxicity-Pathway-Based Risk Assessment Preparing for Paradigm Change: A Symposium Summary (2010) / Chapter Skim
Currently Skimming:

Appendix C: Symposium Agenda
Pages 63-69

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 63...
... Appendix C Symposium Agenda TOXICITY-PATHWAY-BASED RISK ASSESSMENT: PREPARING FOR PARADIGM CHANGE Public Meeting: May 11-13, 2009 National Academy of Sciences 2101 Constitution Avenue, NW Washington, DC 20418 MONDAY, MAY 11, 2009 A PARADIGM CHANGE ON THE HORIZON 8:30 Welcome and Introduction Warren Muir Executive Director, Division on Earth and Life Studies National Academies 8:35 Background on Standing Committee on Risk Analysis Issues and Reviews Bernard Goldstein Chair, Standing Committee on Risk Analysis Issues and Reviews Professor, Department of Environmental and Occupational Health University of Pittsburgh 8:40 EPA Expectations on Symposium Peter Preuss Director, National Center for Environmental Assessment U.S. Environmental Protection Agency 63
Read the entire page →
From page 64...
... Baetjer Professor of Environmental Health and Chair Department of Environmental Health Sciences Johns Hopkins Bloomberg School of Public Health
Read the entire page →
From page 65...
... Environmental Protection Agency 2:00 Practical Applications: Pharmaceuticals William Pennie Executive Director, Compound Safety Prediction Worldwide Medicinal Chemistry Pfizer Global Research and Development 2:30 Practical Applications: Consumer Products George Daston Research Fellow Procter & Gamble Company 3:00 Break 3:15 Practical Applications: Mixtures John Groten Vice President, Drug Safety Europe Schering-Plough
Read the entire page →
From page 66...
... 5:00 Break 5:30 Poster Session 7:00 Adjourn TUESDAY, MAY 12, 2009 APPLICATION TO MODE-OF-ACTION ANALYSIS Moderator: Lauren Zeise, Member, Symposium Planning Committee; Chief, Reproductive and Cancer Hazard Assessment Section, California Environmental Protection Agency 8:30 What is Required for Acceptance John Bucher Associate Director, National Toxicology Program National Institute of Environmental Health Sciences 9:00 Environmental Disease: Evaluation at the Molecular Level Kenneth Ramos Distinguished Professor, Department of Biochemistry and Molecular Biology University of Louisville Health Science Center 9:30 Dioxin: Evaluation of Pathways at the Molecular Level Alvaro Puga Professor University of Cincinnati
Read the entire page →
From page 67...
... Kedderis Independent Researcher and Consultant Chapel Hill, North Carolina
Read the entire page →
From page 68...
... Professor, Department of Biochemistry and Molecular and Cellular Biology, Biomedical Graduate Research Organization; Department of Oncology, Lombardi Comprehensive Cancer Center Georgetown University 3:45 The FDA Experience in Analyzing Genomic Data Federico Goodsaid Associate Director for Operations in Genomics U.S. Food and Drug Administration 4:15 Panel Discussion 5:30 Adjourn WEDNESDAY, MAY 13, 2009 WHAT THE FUTURE HOLDS Moderator: Lorenz Rhomberg, Chair, Symposium Planning Committee; Member, Standing Committee on Risk Analysis Issues and Reviews; Principal, Gradient Corporation 8:30 Are we "there" yet and Where is "there"?
Read the entire page →
From page 69...
... Appendix C 69 A Perspective from NIEHS John Bucher Associate Director, National Toxicology Program National Institute of Environmental Health Sciences A Perspective from the Chemical Industry Tina Bahadori Managing Director Long Range Research Initiative American Chemistry Council A Perspective from the Pharmaceutical Industry Roger Ulrich Chief Development Officer Calistoga Pharmaceuticals, Inc. A Perspective from Academia Helmut Zarbl Professor of Environmental and Occupational Medicine University of Medicine and Dentistry of New Jersey A Perspective from an Environmental Advocacy Group Gina Solomon Senior Scientist Natural Resources Defense Council 10:30 Break 10:45 Panel Discussion 11:45 Symposium Close Lorenz Rhomberg Chair, Symposium Planning Committee Member, Standing Committee on Risk Analysis Issues and Reviews Principal, Gradient Corporation 12:00 Adjourn
Read the entire page →

Key Terms

  • planning committee
  • risk analysis
  • standing committee
  • analysis issues
  • panel discussion

  • lorenz rhomberg
  • gradient corporation
  • compound safety
  • cellular biology
  • cancer hazard

  • pfizer global
  • drug safety
  • bloomberg school
  • assessment section
  • louisville health

  • worldwide medicinal
  • lombardi comprehensive
  • comprehensive cancer
  • research organization
  • science center

  • global research
  • lauren zeise
  • california environmental
  • environmental assessment
  • safety europe

  • national toxicology
  • future holds
  • genomic data
  • epa peter
  • analyzing genomic


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.